Haleon’s Sri Lanka manufacturing facility in Ratmalana, had the honour of hosting UK’s Trade Envoy to Sri Lanka Lord Hannett of Everton. He was accompanied by Mr. Andrew Patrick, British High Commissioner, Ms.Anna Shotbolt, Deputy Trade Commissioner, South Asia, Ms. Mara Waters, Director of Trade, Sri Lanka, Ms. Asanthi Fernando, Deputy Head of Trade & Investment and Ms. Shameema Yusuf, UK Trade Envoy Relationship Manager, APAC & South Asia.

The visit provided Haleon Sri Lanka with a unique opportunity to showcase current initiatives and ambitious future plans aimed at fostering innovation and driving economic development. The delegation was taken through a comprehensive tour of Haleon’s Liquid and Tablet manufacturing facilities, highlighting its impressive legacy and operations. The unit not only delivers quality healthcare to Sri Lankans but also exports to other markets globally.

The Ratmalana manufacturing facility stands as a testament to Haleon’s enduring commitment to delivering better everyday health with humanity.

Chanaka Wanniarachchi, Managing Director, Sri Lanka & Maldives, Haleon Lanka, “Since 1956, Haleon has contributed to providing high-quality medicines that meet global standards, while investing in the development of Sri Lanka’s pharmaceutical workforce. As an industry leader, we are proud to have created meaningful employment, transferred critical skills, and helped strengthen the country’s healthcare ecosystem. Our efforts support a healthier and more skilled nation, as well as further deepen the longstanding UK–Sri Lanka partnership in pharmaceutical technology and healthcare innovation.”

Andrew Patrick, British High Commissioner to Sri Lanka, “It was a pleasure to visit Haleon’s Ratmalana facility and witness the remarkable contribution it continues to make to Sri Lanka’s healthcare sector. This site not only reflects the strength of the UK–Sri Lanka trade and investment partnership but also highlights the value of long-standing British businesses in empowering local talent, advancing innovation, and supporting sustainable economic development.”

The Haleon Sri Lanka facility, part of the global consumer healthcare company Haleon UK (erstwhile GlaxoSmithKline Consumer Health), has been proudly managed by Sri Lankans since 1956, and is dedicated to improving the health and well-being of consumers. Haleon’s extensive portfolio includes well-known brands such as Sensodyne, Panadol, ENO, Iodex, Corsodyl, Voltaren and Piritonthat help millions of Sri Lankans live healthier lives. Sensodyne provides effective relief from tooth sensitivity, allowing individuals to enjoy their favorite foods and drinks without discomfort. Panadol offers fast and effective pain relief, while ENO helps with quick relief from acidity and indigestion. Iodex provides targeted relief for muscle pain, and Corsodyl supports gum health. Voltaren is known for its powerful anti-inflammatory properties, Together, these trusted brands contribute to the overall well-being and health of the community.

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon’s product portfolio spans six major categories – Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands are built on trusted science, innovation and deep human understanding.

The post High-Profile UK Delegation visits Haleon’s Manufacturing Facility in Ratmalana appeared first on Newswire.

Haleon Sri Lanka, the makers of Sensodyne, conducted a successful series of impactful oral health initiatives island wide in celebration of Oral Health Day 2025. The campaign, implemented in partnership with the Sri Lanka Dental Association (SLDA), reached millions of Sri Lankans through awareness programs and free dental screenings.

The nationwide initiative, focused on the theme ‘#BeSensitiveToOralHealth: Take the First Step’ to spread awareness around the significance of Oral Health and to prompt Sri Lankans to take the first step towards better oral health practices. The program specifically targeted dental sensitivity, a common condition affecting a significant portion of the population.

Professor Ruwan Jayasinghe, President, Sri Lanka Dental Association, stated, “We sincerely thank Haleon Sri Lanka for championing this national event. Their proactive support and comprehensive resource provision have been crucial to the success of Oral Health Day 2025 initiatives, demonstrating the powerful impact of corporate-professional partnerships on public health.”

Chanaka Wanniarachchi, Country Lead, Haleon Sri Lanka and Maldives, added, “Oral health is fundamental to overall wellbeing, yet it remains neglected by many Sri Lankans. Through our partnership with the SLDA, we’ve been able to combine expertise and resources to make a meaningful difference in how people approach their oral health care.”

The comprehensive campaign featured awareness programs where educational sessions conducted by Members of the SLDA, highlighted proper brushing techniques, the importance of regular dental check-ups, and specific guidance for managing sensitive teeth. Additionally, dental screening camps provided free dental examinations covering multiple locations, allowingover 50,000 participants to receive professional assessments and personalized advice.

Harsha Ratnayake, Marketing Lead, Haleon Lanka said, “The prevalence of dental sensitivity issues in Sri Lanka demands focused attention and practical solutions. We are confident that the initiatives have encouraged millions of Sri Lankans to recognize the importance of oral health and take those crucial first steps toward better oral care practices.”

Manjula Wijekoon, Commercial Lead, Haleon Sri Lanka and Maldives, emphasized, “As a responsible healthcare company, Haleon will continue supporting this national cause and expand programs aimed at uplifting Sri Lankans’ oral health. The initiative reflects our broader mission to deliver better everyday health with humanity.”

Sensodyne, Haleon’s leading sensitivity Toothpaste and Toothbrush brand, has been at the forefront of addressing dental sensitivity worldwide. Through the collaboration with SLDA, Haleon has reinforced its dedication to oral health education and accessibility in Sri Lanka.

The company plans to build on the success of this campaign with ongoing initiatives throughout the year, ensuring that the momentum toward better oral health continues beyond Oral Health Day.

The post Sensodyne and SLDA partnership touches millions through nationwide initiatives on Oral Health Day 2025 appeared first on Newswire.